#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3887026	Binding	qHTS Assay: Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through luminescence generated from firefly luciferase, a bioluminescent ATP-dependent enzymes. ATP was held at 35 μM, near its reported KM value, and the KM for galactose was determined under the 1536-well assay conditions to be 50-100M (FIG. 1A). As well, the IC50 for a commercially available CD45 inhibitor (N-(9,10-dioxo-9,10-dihydrophenanthren-2-yl)pivalamide) was confirmed (previously found to inhibit GALK (FIG. 1B)). This was used as the positive control for the assay. The assay used 5 nM GALK and a 1 hr incubation time, which gave sufficient signal:background and stability for the HTS.		88	ALA3886142	single protein format	BindingDB Database
2.	ALA5052897	Binding	Inhibition of GALK (unknown origin) incubated for 1 hr and measured by qHTS assay	Homo sapiens	91	ALA5052821	single protein format	Patent Bioactivity Data
3.	ALA5052898	Binding	Inhibition of GALK (unknown origin) incubated for 1 hr and measured by qHTS assay realtive to control	Homo sapiens	91	ALA5052821	single protein format	Patent Bioactivity Data
4.	ALA5052899	Binding	Inhibition of bacterial CDP-ME kinase assessed as ATP depletion up to 57 uM measured by bioluminescent kinase Glo assay	Bacteria	91	ALA5052821	assay format	Patent Bioactivity Data